Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | CRSP | CYTK | ||
| Company | Denali Therapeutics Inc | Crispr Therapeutics Ag | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.92 | 54.12 | 44.00 | ||
| High | 32.81 | 56.11 | 45.19 | ||
| Low | 31.52 | 53.38 | 43.47 | ||
| Last | 31.70 | 55.27 | 45.01 | ||
| Change | -0.97 | -0.85 | +0.45 | ||
| % Change | -2.97% | -1.51% | +1.01% | ||
| Volume | 517,900 | 1,166,700 | 998,300 | ||
| 20-Day Average Volume | 634,565 | 1,066,445 | 872,530 | ||
| Previous Close | 32.67 | 56.12 | 44.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.88 | 50.58 | 42.75 | ||
| 20-Day Raw Stochastic | 81.53% | 74.63% | 96.50% | ||
| 20-Day Relative Strength | 56.23% | 58.53% | 56.49% | ||
| Weighted Alpha | -6.80 | -11.90 | +21.30 | ||
| Today's Opinion | 72% Buy | 24% Sell | 8% Buy | ||
| Previous Opinion | 72% Buy | 24% Sell | 8% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.73% since 01/27/23 | +4.72% since 01/27/23 | +4.38% since 01/27/23 | ||
| Low | 30.00 on 01/31/23 | 49.86 on 01/30/23 | 40.83 on 02/01/23 | ||
| High | 32.81 on 02/03/23 | 58.50 on 02/02/23 | 45.19 on 02/03/23 | ||
| 1-Month | |||||
| %Chg | +14.73% since 01/03/23 | +34.80% since 01/03/23 | +1.49% since 01/03/23 | ||
| Low | 26.80 on 01/11/23 | 41.20 on 01/04/23 | 40.18 on 01/12/23 | ||
| High | 32.81 on 02/03/23 | 58.50 on 02/02/23 | 45.19 on 02/03/23 | ||
| 3-Month | |||||
| %Chg | +3.49% since 11/03/22 | +3.81% since 11/03/22 | +13.23% since 11/03/22 | ||
| Low | 25.96 on 12/20/22 | 38.94 on 12/30/22 | 35.35 on 12/08/22 | ||
| High | 32.99 on 12/05/22 | 64.22 on 11/15/22 | 47.49 on 12/22/22 | ||
| 6-Month | |||||
| %Chg | -4.55% since 08/03/22 | -29.66% since 08/03/22 | +5.07% since 08/03/22 | ||
| Low | 25.88 on 09/26/22 | 38.94 on 12/30/22 | 35.35 on 12/08/22 | ||
| High | 39.43 on 08/11/22 | 84.10 on 08/08/22 | 55.80 on 09/09/22 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,305,304 | 4,327,309 | 4,259,341 | ||
| Shares Outstanding, K | 135,814 | 78,294 | 94,631 | ||
| Annual Sales | 48,660,000 | 914,960,000 | 70,430,000 | ||
| Annual Net Income | -290,580,000 | 377,660,000 | -215,310,000 | ||
| Last Quarter Sales | 3,560,000 | 90,000 | 2,520,000 | ||
| Last Quarter Net Income | -103,300,000 | -174,550,000 | -142,310,000 | ||
| 60-Month Beta | 1.37 | 1.66 | 0.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.84 on 11/03/22 | -2.24 on 11/01/22 | -1.28 on 11/03/22 | ||
| Latest Earnings Date | 02/27/23 | 02/21/23 | 02/23/23 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
